Skip to content

Histidine-Rich Glycoprotein as a Novel Prognostic Biomarker in Septic Patients: Prospective Observational Study

Histidine-Rich Glycoprotein as a Novel Prognostic Biomarker in Septic Patients: Prospective Observational Study - HRG-Observational

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000017651
Enrollment
100
Registered
2015-05-22
Start date
2014-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

None listed

Sponsors

Department of Anesthesiology and Resuscitology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients newly diagnosed sepsis.

Exclusion criteria

Exclusion criteria: Pregnancy and Patients with transplantation

Design outcomes

Primary

MeasureTime frame
Relation between the HRG levels and mortality

Secondary

MeasureTime frame
Relations between the HRG levels and other parameters

Countries

Japan

Contacts

Public ContactKosuke Kuroda

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Anesthesiology and Resuscitology

kosa-tym@umin.net+81-86-235-7327

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026